-
Natrecor Safety Controversy Considered In Two May 2007 Medical Journal Articles
Is Natrecor An Example Of Why Dr. Steven Nissen Thinks That The FDA Is Dysfunctional And In Need Of Reform? (Posted by Tom Lamb at DrugInjuryWatch.com) Natrecor (nesiritide) is approved for the treatment of…
-
FDA Now Provides Emerging Drug Safety Information By Means Of Audio Broadcasts, Or Podcasts
Recent Subjects Have Been Drug Recalls Involving IBS Medication Zelnorm And Parkinson’s Drug Permax (Posted by Tom Lamb at DrugInjuryWatch.com) An April 20, 2007 FDA News item reminded doctors and other health care professionals…
-
Tysabri And PML: No New Reports Of Serious Brain Infection PML According To Biogen And Elan
Drug Companies Also State There Have Been No Reports Of Other "Serious Opportunistic Infections" Related To Recent Use Of Tysabri (Posted by Tom Lamb at DrugInjuryWatch.com) In a May 3, 2007 Wall Street Journal…
-
May 2007 FDA “Patient Safety News” Videos For Doctors Online
Covers Procrit, Aranesp & Epogen, As Well As Adderall, Ambien, And More (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily…
-
More Than One Million Hospitalized Patients Experienced Adverse Drug Reactions (ADRs) In 2004
Findings Of April 2007 AHRQ Report On Side Effects And Other Medication Problems In American Hospitals (Posted by Tom Lamb at DrugInjuryWatch.com) A recent online article provided a summary of the findings from the…
-
Former FDA Physician David Ross Criticizes Agency’s Handling Of Ketek Case In April 2007 NEJM Article
FDA Staffers’ Letter To Editor Defends Steps Taken Over Time As Regards This Controversial Sanofi-Aventis Antibiotic (Posted by Tom Lamb at DrugInjuryWatch.com) In the April 19, 2007 New England Journal of Medicine (NEJM) appears…